nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A phase II randomized controlled study of pegylated liposomal doxorubicin and carboplatin vs. gemcitabine and carboplatin for platinum-sensitive recurrent ovarian cancer (GOTIC003/intergroup study)
|
Fujiwara, Hiroyuki |
|
2019 |
24 |
10 |
p. 1284-1291 |
artikel |
2 |
A single-arm, phase 2 study of steroid-containing mouthwash for the prevention of everolimus-associated stomatitis in multiple tumor types
|
Hattori, Masaya |
|
2019 |
24 |
10 |
p. 1320-1327 |
artikel |
3 |
Clinical significance of prognostic nutritional index (PNI) in malignant melanoma
|
Mirili, Cem |
|
2019 |
24 |
10 |
p. 1301-1310 |
artikel |
4 |
Clinical significance of the pattern-based classification in endocervical adenocarcinoma, usual and variants
|
Byun, Jung Mi |
|
2019 |
24 |
10 |
p. 1264-1272 |
artikel |
5 |
Familial cancer of unknown primary
|
Rassy, Elie |
|
2019 |
24 |
10 |
p. 1328-1331 |
artikel |
6 |
Frequency and predictors of detecting early locoregional recurrence/disease progression of oral squamous cell carcinoma with high-risk factors on imaging tests before postoperative adjuvant radiotherapy
|
Kibe, Yuichi |
|
2019 |
24 |
10 |
p. 1182-1189 |
artikel |
7 |
Immune checkpoint inhibitor-induced sarcoidosis-like granulomas
|
Rambhia, Pooja H. |
|
2019 |
24 |
10 |
p. 1171-1181 |
artikel |
8 |
Late start and insufficient S-1 dose in adjuvant chemotherapy can lead to poor prognosis in stage II/III gastric cancer
|
Miyatani, Kozo |
|
2019 |
24 |
10 |
p. 1190-1196 |
artikel |
9 |
Multicenter phase II study of biweekly CAPIRI plus bevacizumab as second-line therapy in patients with metastatic colorectal cancer (JSWOG-C3 study)
|
Suzuki, Nobuaki |
|
2019 |
24 |
10 |
p. 1223-1230 |
artikel |
10 |
Phase II study of S-1 on alternate days plus bevacizumab in patients aged ≥ 75 years with metastatic colorectal cancer (J-SAVER)
|
Moriwaki, Toshikazu |
|
2019 |
24 |
10 |
p. 1214-1222 |
artikel |
11 |
Predictors of favorable survival after secondary cytoreductive surgery for recurrent endometrial cancer
|
Shikama, Ayumi |
|
2019 |
24 |
10 |
p. 1256-1263 |
artikel |
12 |
Prognostic factors and survival in Japanese patients with brain metastasis from renal cell cancer
|
Takeshita, Nobushige |
|
2019 |
24 |
10 |
p. 1231-1237 |
artikel |
13 |
Prognostic implication of adjuvant/neoadjuvant chemotherapy consisting of doxorubicin and ifosfamide in patients with extraskeletal osteosarcoma
|
Wakamatsu, Toru |
|
2019 |
24 |
10 |
p. 1311-1319 |
artikel |
14 |
Skeletal muscle loss during systemic chemotherapy for colorectal cancer indicates treatment response: a pooled analysis of a multicenter clinical trial (KSCC 1605-A)
|
Sasaki, Shun |
|
2019 |
24 |
10 |
p. 1204-1213 |
artikel |
15 |
Systemic chemotherapy for gastric cancer with early recurrence after adjuvant S-1 monotherapy: a multicenter retrospective study
|
Mitani, Seiichiro |
|
2019 |
24 |
10 |
p. 1197-1203 |
artikel |
16 |
Ten-year outcomes of high-dose intensity-modulated radiation therapy for nonmetastatic prostate cancer with unfavorable risk: early initiation of salvage therapy may replace long-term adjuvant androgen deprivation
|
Aizawa, Rihito |
|
2019 |
24 |
10 |
p. 1247-1255 |
artikel |
17 |
Thrombotic events induce the worse prognosis in ovarian carcinomas and frequently develop in ovarian clear cell carcinoma
|
Takasaki, Kazuki |
|
2019 |
24 |
10 |
p. 1273-1283 |
artikel |
18 |
Time to biochemical relapse after radical prostatectomy and efficacy of salvage radiotherapy in patients with prostate cancer
|
Pak, Sahyun |
|
2019 |
24 |
10 |
p. 1238-1246 |
artikel |
19 |
Volumetric and texture analysis on FDG PET in evaluating and predicting treatment response and recurrence after chemotherapy in follicular lymphoma
|
Tatsumi, Mitsuaki |
|
2019 |
24 |
10 |
p. 1292-1300 |
artikel |